Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms
Authors:
- Richard P. BaumRBRichard P. Baum
- Harshad R. KulkarniHKHarshad R. Kulkarni
- Cecilia CarrerasCCCecilia Carreras
Open Access
- 1 May 2012
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 42 (3) , 190-207
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CTInternational Journal of Molecular Imaging, 2011
- 68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine TumorsJournal of Nuclear Medicine, 2011
- Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)European Journal of Nuclear Medicine and Molecular Imaging, 2011
- Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?European Journal of Nuclear Medicine and Molecular Imaging, 2011
- 68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor–Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine TumorsJournal of Nuclear Medicine, 2010
- 111In-pentetreotide scintigraphy: procedure guidelines for tumour imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analoguesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008